New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 7, 2014
07:30 EDTILMNIllumina weakness creates buying opportunity, says Wells Fargo
Wells Fargo believes that the recent decline in Illumina's stock is mostly related to its correlation with biotech indices, and the firm sees this correlation as "a technical rather than a fundamental phenomenon." The firm believes that demand for the company's HiSeq, MiSeq, and HiSeq X instruments are strong, and it now identifies the stock as its top pick in the tools space. It increased its price target on the shares to $170-175 from $155-$160.
News For ILMN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 26, 2015
06:41 EDTILMNIllumina Accelerator secures $40M boost capital from Viking Global Investors
Subscribe for More Information
February 25, 2015
07:18 EDTILMNG Corp to hold annual meeting
Subscribe for More Information
February 19, 2015
09:09 EDTILMNLeerink's life science tools analyst holds an analyst/industry conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use